ad image

Postpartum Depression

1 / 1
Unlocking the Potential of Psychedelics for Postpartum Depression
Psychedelics

Unlocking the Potential of Psychedelics for Postpartum Depression

Greg Mayes, J.D.

Reunion Neuroscience

PAO-03-25-CL-05Mar 31, 2025
U.S. Food & Drug Administration
FDA Approval

FDA Approves First Treatment for Postpartum Depression

U.S. Food & Drug Administration

PR-M03-19-NI-064Mar 22, 2019
Sage Therapeutics
FDA Acceptance

Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression

Sage Therapeutics

PR-M06-18-NI-007Jun 04, 2018
1 / 1